Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
65.57 USD | -1.83% | +1.58% | +4.41% |
05-08 | Vaxcyte, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-25 | Vaxcyte Insider Sold Shares Worth $928,845, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.41% | 7.13B | |
+2.97% | 108B | |
+10.21% | 104B | |
+2.56% | 22.33B | |
-12.77% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-6.50% | 17.64B | |
+6.00% | 14.05B | |
+37.20% | 12.51B |
- Stock Market
- Equities
- PCVX Stock
- News Vaxcyte, Inc.
- Vaxcyte Shares Rise After Completion of Enrollment for Phase 1/2 Clinical Study Assessing Vaccine Candidate